Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular targets and anticancer activity of quinoline–chalcone hybrids: literature review
Mamdouh F. A. Mohamed, Gamal El‐Din A. Abuo‐Rahma
RSC Advances (2020) Vol. 10, Iss. 52, pp. 31139-31155
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

Anticancer Activity of Natural and Synthetic Chalcones
Teodora Constantinescu, Claudiu N. Lungu
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11306-11306
Open Access | Times Cited: 110
Discovery of a novel series of substituted quinolines acting as anticancer agents and selective EGFR blocker: Molecular docking study
C.B. Pradeep Kumar, M.S. Raghu, B.S. Prathibha, et al.
Bioorganic & Medicinal Chemistry Letters (2021) Vol. 44, pp. 128118-128118
Closed Access | Times Cited: 89
Anticancer activities of tetra-, penta-, and hexacyclic phenothiazines modified with quinoline moiety.
Małgorzata Jeleń, Beata Morak‐Młodawska, Rafał Korlacki
Journal of Molecular Structure (2023) Vol. 1287, pp. 135700-135700
Open Access | Times Cited: 19
Synthesis, anticancer activity and molecular docking of new quinolines, quinazolines and 1,2,4-triazoles with pyrido[2,3-d] pyrimidines
Ameen A. Abu‐Hashem, Othman Hakami, Nasser Amri
Heliyon (2024) Vol. 10, Iss. 5, pp. e26735-e26735
Open Access | Times Cited: 11
Inhibition of cancer cells by Quinoline-Based compounds: A review with mechanistic insights
Anjali Saxena, Suman Majee, Devalina Ray, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 103, pp. 117681-117681
Closed Access | Times Cited: 10
Michael Acceptors as Anti-Cancer Compounds: Coincidence or Causality?
Celia María Curieses Andrés, José Manuel Pérez de la Lastra, Elena Bustamante Munguira, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6099-6099
Open Access | Times Cited: 9
Recent advance in the development of N-heterocyclic derivatives as anti-SARS-CoV-2 inhibitors: A review
Walid Ettahiri, Mohamed Adardour, Siham Alaoui, et al.
Phytochemistry Letters (2024) Vol. 61, pp. 247-269
Closed Access | Times Cited: 8
Synthesis, in vitro potency of inhibition, enzyme kinetics and in silico studies of quinoline-based α-glucosidase inhibitors
Minoo Khalili Ghomi, Navid Dastyafteh, Mohammad Nazari Montazer, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
An insight into sustainable and green chemistry approaches for the synthesis of quinoline derivatives as anticancer agents
B. Kumaraswamy, K. Hemalatha, Rohit Pal, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116561-116561
Closed Access | Times Cited: 7
Copper-catalyzed dehydrogenative cyclization/alkenylation towards dihydroquinolinones
K. Pari, Nawaz Khan Fazlur-Rahman
Organic & Biomolecular Chemistry (2024) Vol. 22, Iss. 20, pp. 4163-4171
Closed Access | Times Cited: 6
From Infection to Tumor: Exploring the Therapeutic Potential of Ciprofloxacin Derivatives as Anticancer Agents
Hesham M. Hassan, Roket Hassan, Ranya Mohammed Elmagzoub, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 72-72
Open Access
A tandem approach for the synthesis of 1-phenyl-pyrazolo-quinolinones by Fe 3 O 4 @MWCNT nanocomposite as heterogeneous catalyst
Adapaka Venkateswara Rao, Suresh Maddila, Nagaraju Kerru, et al.
Green Chemistry Letters and Reviews (2025) Vol. 18, Iss. 1
Open Access
Activation of Nrf2 signaling pathway by natural and synthetic chalcones: a therapeutic road map for oxidative stress
Melford C. Egbujor, Sarmistha Saha, Brigitta Buttari, et al.
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 4, pp. 465-480
Open Access | Times Cited: 42
The Versatile Quinoline and Its Derivatives as anti-Cancer Agents: An Overview
Basavarajaiah Suliphuldevara Mathada
Polycyclic aromatic compounds (2022) Vol. 43, Iss. 5, pp. 4333-4345
Closed Access | Times Cited: 34
Friedlӓnder's synthesis of quinolines as a pivotal step in the development of bioactive heterocyclic derivatives in the current era of medicinal chemistry
Rajendran Satheeshkumar, Kalaiselvi Sivalingam, Karnam Jayarampillai Rajendra Prasad, et al.
Chemical Biology & Drug Design (2022) Vol. 100, Iss. 6, pp. 1042-1085
Closed Access | Times Cited: 30
Design, synthesis, and biological evaluation of novel quinoline derivatives as small molecule mutant EGFR inhibitors targeting resistance in NSCLC: In vitro screening and ADME predictions
Ramakant A. Kardile, Aniket P. Sarkate, Deepak K. Lokwani, et al.
European Journal of Medicinal Chemistry (2022) Vol. 245, pp. 114889-114889
Closed Access | Times Cited: 29
Click reaction inspired synthesis, antimicrobial evaluation and in silico docking of some pyrrole-chalcone linked 1,2,3-triazole hybrids
Monika Yadav, Kashmiri Lal, Aman Kumar, et al.
Journal of Molecular Structure (2022) Vol. 1273, pp. 134321-134321
Closed Access | Times Cited: 26
Design, synthesis, cytotoxic activities, and molecular docking of chalcone hybrids bearing 8-hydroxyquinoline moiety with dual tubulin/EGFR kinase inhibition
Mohammed M. Amin, Gamal El‐Din A. Abuo‐Rahma, Montaser Sh. A. Shaykoon, et al.
Bioorganic Chemistry (2023) Vol. 134, pp. 106444-106444
Closed Access | Times Cited: 15
Quinoline‐based thiazolidinone derivatives as potent cytotoxic and apoptosis‐inducing agents through EGFR inhibition
Mohamed S. Nafie, Safaa M. Kishk, Sebaey Mahgoub, et al.
Chemical Biology & Drug Design (2021) Vol. 99, Iss. 4, pp. 547-560
Closed Access | Times Cited: 32
Quinoline conjugated 2-azetidinone derivatives as prospective anti-breast cancer agents: In vitro antiproliferative and anti-EGFR activities, molecular docking and in-silico drug likeliness studies
K. Govindarao, N. Srinivasan, R. Suresh, et al.
Journal of Saudi Chemical Society (2022) Vol. 26, Iss. 3, pp. 101471-101471
Open Access | Times Cited: 25
Design, synthesis, and molecular docking of novel pyrazole-chalcone analogs of lonazolac as 5-LOX, iNOS and tubulin polymerization inhibitors with potential anticancer and anti-inflammatory activities
Asmaa Ahmed, Mamdouh F. A. Mohamed, Rasha M. Allam, et al.
Bioorganic Chemistry (2022) Vol. 129, pp. 106171-106171
Closed Access | Times Cited: 25
Development of penipanoid C-inspired 2-benzoyl-1-methyl-2,3-dihydroquinazolin-4(1H)-one derivatives as potential EGFR inhibitors: Synthesis, anticancer evaluation and molecular docking study
K. Veena, M.S. Raghu, K. Yogesh Kumar, et al.
Journal of Molecular Structure (2022) Vol. 1258, pp. 132674-132674
Closed Access | Times Cited: 21
Medicinally Privileged Natural Chalcones: Abundance, Mechanisms of Action, and Clinical Trials
Sophia M. Villa, J.E. Heckman, Debasish Bandyopadhyay
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9623-9623
Open Access | Times Cited: 3
Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study
Tarek S. Ibrahim, Ahmad J. Almalki, Amr H. Moustafa, et al.
Bioorganic Chemistry (2021) Vol. 111, pp. 104885-104885
Closed Access | Times Cited: 30
Novel quinoxaline derivatives as dual EGFR and COX-2 inhibitors: synthesis, molecular docking and biological evaluation as potential anticancer and anti-inflammatory agents
Eman A. Ahmed, Mamdouh F. A. Mohamed, Omran A. Omran
RSC Advances (2022) Vol. 12, Iss. 39, pp. 25204-25216
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top